Find Clinical Trial
Evaluation of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion at the dose of 5 mg of ivabradine given after a percutaneous coronary intervention following a myocardial infarction with ST segment elevation
← Back
| Study Phase |
Phase 2 |
| Therapeutic Area |
Cardiovascular Diseases |
| Indication | Coronary Artery Disease |
| Sponsor | Institut de Recherches Internationales Servier (I.R.I.S) |
| Active substance/ Medical device |
IVABRADINE, |
| Active Substance Code | S016257 |
| Protocol Code | CL2-16257-060 |
| EudraCT Code | 2005-005122-31 |
| ISRCTN Code | ISRCTN66067800 |
Documents and links
| Results summary | READ MORE  |
Servier Glossary of Terms
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.
© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility
